Last reviewed · How we verify

Drug: 99mTc-MIP-1404

Molecular Insight Pharmaceuticals, Inc. · Phase 2 active Small molecule

Drug: 99mTc-MIP-1404 is a Small molecule drug developed by Molecular Insight Pharmaceuticals, Inc.. It is currently in Phase 2 development. Also known as: MIP-1404.

At a glance

Generic nameDrug: 99mTc-MIP-1404
Also known asMIP-1404
SponsorMolecular Insight Pharmaceuticals, Inc.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Drug: 99mTc-MIP-1404

What is Drug: 99mTc-MIP-1404?

Drug: 99mTc-MIP-1404 is a Small molecule drug developed by Molecular Insight Pharmaceuticals, Inc..

Who makes Drug: 99mTc-MIP-1404?

Drug: 99mTc-MIP-1404 is developed by Molecular Insight Pharmaceuticals, Inc. (see full Molecular Insight Pharmaceuticals, Inc. pipeline at /company/molecular-insight-pharmaceuticals-inc).

Is Drug: 99mTc-MIP-1404 also known as anything else?

Drug: 99mTc-MIP-1404 is also known as MIP-1404.

What development phase is Drug: 99mTc-MIP-1404 in?

Drug: 99mTc-MIP-1404 is in Phase 2.

Related